Cases 91 - 100 of 577
KAY v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv01822
Plaintiff:
JO KAY
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
SCACCIAFERRO v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv01831
Plaintiff:
JANE SCACCIAFERRO
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
FORE et al v. MYLAN LABORATORIES LTD. et al
as 1:2022cv01692
Plaintiff:
MARK FORE and BARBARA FORE
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., MYLAN PHARMACEUTICALS INC. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BAILEY v. MYLAN LABORATORIES LTD. et al
as 1:2022cv01518
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
ROBERT LOUIS BAILEY
Defendant:
MYLAN LABORATORIES LTD., MYLAN N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
RESTIVO v. MYLAN LABORATORIES LTD. et al
as 1:2022cv01442
Plaintiff:
ANGELA RESTIVO and ESTATE OF JOHN RESTIVO
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
WALKER v. AUROBINDO PHARMA, LTD. et al
as 1:2022cv01372
Plaintiff:
SHELDON WALKER
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
BAUSCH HEALTH IRELAND LIMITED et al v. MYLAN LABORATORIES LTD. et al
as 1:2022cv00020
Plaintiff:
Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc
Defendant:
Mylan Laboratories Ltd., Agila Specialties Inc., Mylan API US LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
KIM v. MYLAN LABORATORIES, LTD. et al
as 1:2022cv01084
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
HAESEOK KIM
Defendant:
MYLAN LABORATORIES, LTD., MYLAN, N.V., MYLAN PHARMACEUTICALS INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
DARABARIS v. MYLAN LABORATORIES LTD. et al
as 1:2022cv01048
Plaintiff:
JEREMY DARABARIS
Defendant:
MYLAN LABORATORIES LTD., MYLAN, N.V., ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
GALLAGHER v. HETERO DRUGS, LTD. et al
as 1:2022cv00930
Plaintiff:
KELLY GALLAGHER
Defendant:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION, HETERO DRUGS, LTD., HETERO LABS, LTD. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
